分岐病変の世界市場レポート 2025年

分岐病変市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.9％で40億2,000万米ドルに成長します。予測期間の成長は、低侵襲手術に対する需要の増加、医療インフラと施設の拡大、心血管疾患の有病率の増加、政府の医療施策に起因しています。予測期間の主要動向には、患者中心のアプローチ、生体吸収性ステント、AIと機械学習の統合、専門セグメントを超えた連携などがあります。

分岐病変市場の成長は、高齢者の増加によって牽引されると予測されます。60歳以上の高齢者は、心臓発作、脳卒中、冠動脈性心疾患、心不全などの心臓関連の問題にかかりやすいです。分岐病変は、このような場合に血栓を治療し、心臓への十分な血流を促進する上で重要な役割を果たします。世界保健機関（WHO）の報告によると、2030年には世界の6人に1人が60歳以上の高齢者になり、2050年には80歳以上の高齢者が現在の人口より4億2,600万人増えると予測されています。高齢者の増加は、分岐病変市場の重要な促進要因になると予測されます。

医療支出の増加は、今後の分岐病変市場の成長を牽引すると予測されます。医療インフラには、医療、予防対策、公衆衛生活動、リハビリテーション、地域保健活動、健康調査などに関するすべての費用が含まれます。医療支出の増加により、医療施設は分岐病変を治療するための先進的なインターベンショナルカーディオロジー機器など、最先端の機器や技術に投資することができます。例えば、2023年11月、カナダに本部を置く非営利団体Canadian Institute for Health Informationは、2022年のわずか1.5％という緩やかな成長に続き、2023年にはカナダの総医療費が2.8％増加すると予測しました。その結果、医療支出の増加が分岐病変市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界の分岐病変PESTEL分析（政治、社会、技術、環境、法的、促進要因、制約要因）
• 最終用途産業の分析
• 世界の分岐病変市場成長率分析
• 世界の分岐病変市場の実績：規模と成長、2019～2024年
• 世界の分岐病変市場の予測：規模と成長、2024～2029年、2034年
• 世界の分岐病変総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の分岐病変市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ワンステント
• 2ステント
• 世界の分岐病変市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 冠動脈血管
• 末梢血管
• 世界の分岐病変市場、1ステントのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 単一ステント
• バルーン拡大型ステント
• 自己拡大型ステント
• 世界の分岐病変市場、2ステントのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• クラッシュテクニック
• T字型またはY字型のステント
• 側枝ステント留置術

第7章 地域別・国別分析

• 世界の分岐病変市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の分岐病変市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 分岐病変市場：競合情勢
• 分岐病変市場：企業プロファイル
  • Boston Scientific Corporation
  • Terumo Medical Corporation
  • Spectranetics Corporation
  • Medtronic plc
  • Cardinal Health Inc.

第31章 その他の大手企業と革新的企業

• Cardinal Health Company
• Abbott Laboratories
• Biosensors International Group Ltd.
• B. Braun Melsungen AG
• Cook Medical LLC
• Cordis Corporation
• Endologix Inc.
• W. L. Gore & Associates Inc.
• InspireMD Inc.
• MicroPort Scientific Corporation
• OrbusNeich Medical Company Limited
• BIoTronik SE & Co. KG
• Cardionovum GmbH
• Elixir Medical Corporation
• Medinol Ltd.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、戦略

• 分岐病変市場、2029年-最も新しい機会を提供する国
• 分岐病変市場、2029年-最も新しい機会を提供するセグメント
• 分岐病変市場、2029年-成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Bifurcation lesions in the context of coronary arteries refer to constrictions that occur adjacent to or involve the origin of a critical side branch that one aims to preserve. This situation arises when there is an accumulation of plaque deposits, causing the artery to become too narrow, thereby hindering adequate blood flow to the heart.

The main categorizations of bifurcation lesions are one-stent and two-stent approaches. In a one-stent bifurcation lesion procedure, the side branch is provisionally stented if intervention is deemed necessary based on clinical complaints, angiographic results, or other relevant factors. In this approach, the main branch is stented first. The bifurcation angle is determined by the internal angle between the main and side branches. These types of bifurcation lesions are encountered in both coronary and peripheral vascular contexts.

The bifurcation lesions market research report is one of a series of new reports from The Business Research Company that provides bifurcation lesions market statistics, including bifurcation lesions industry global market size, regional shares, competitors with a bifurcation lesions market share, detailed bifurcation lesions market segments, market trends and opportunities, and any further data you may need to thrive in the bifurcation lesions industry. This bifurcation lesions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.63 billion in 2024 to $2.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rise in prevalence of coronary artery diseases, rise in geriatric population, rise in healthcare expenditure, economic growth.

The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $4.02 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, expansion of healthcare infrastructure and facilities, increasing prevalence of cardiovascular diseases, government healthcare policies. Major trends in the forecast period include patient-centric approaches, bioresorbable stents, integration of ai and machine learning, cross-specialty collaboration.

The growth of the bifurcation lesions market is expected to be driven by the increasing geriatric population. Individuals aged 60 and above are more susceptible to heart-related issues such as heart attacks, strokes, coronary heart disease, and heart failure. Bifurcation lesions play a crucial role in treating blood clots and facilitating adequate blood flow to the heart in such cases. A report by the World Health Organization (WHO) projected that by 2030, one in six people globally would be 60 or older, and by 2050, the number of individuals aged 80 and above would increase by 426 million compared to the current population. The rise in the geriatric population is anticipated to be a significant driver for the bifurcation lesions market.

The rising healthcare expenditure is expected to drive the growth of the bifurcation lesions market in the future. Healthcare infrastructure encompasses all expenses related to medical care, preventive measures, public health initiatives, rehabilitation, community health activities, and health research. Increased healthcare spending enables healthcare facilities to invest in cutting-edge equipment and technologies, including advanced interventional cardiology devices for treating bifurcation lesions. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization based in Canada, projected that total health spending in Canada would increase by 2.8% in 2023, following a modest growth of only 1.5% in 2022. Consequently, the rising healthcare expenditure is propelling the growth of the bifurcation lesions market.

A key trend gaining popularity in the bifurcation lesions market is the advancement in devices used in imaging and procedures. Leading companies in the market are focusing on enhancing existing devices used in imaging and procedures. For example, Advanced Bifurcation Systems (ABS), a clinical-stage medical device firm, has developed a unique bifurcation stenting solution featuring modular self-aligning stent technology. This platform aims to standardize the treatment of all bifurcation lesions in coronary angioplasties, providing a single system that reduces the need for repeat procedures and enables effective bifurcation stenting treatment. The trend towards device advancement is contributing to the growth and innovation in the bifurcation lesions market.

Leading companies in the bifurcation lesions market are actively developing innovative products such as drug-eluting coronary stent systems to expand their customer base, increase sales, and drive revenue growth. A drug-eluting coronary stent system is a specialized medical device used in interventional cardiology for the treatment of coronary artery disease. In August 2023, Medtronic PLC, an Ireland-based medical device company, introduced the Onyx Frontier drug-eluting stent (DES) to address non-left main bifurcation lesions using the provisional stenting technique. This product incorporates several design enhancements, including a dual-layer balloon, reduced crossing profile, and enhanced catheter flexibility. The improvements result in a 16% enhancement in deliverability compared to the prior-generation Resolute Onyx DES, maintaining the same level of radial strength. Onyx Frontier offers an extensive range of sizes, accommodating patient needs with diameters ranging from 2.0mm to 5.0mm, with specific sizing for the treatment of extra-large vessels, including those in the left main. The product inherits clinical data and indications from Resolute Onyx, including approval for treating bifurcation lesions, left main percutaneous coronary intervention (PCI), and a recommended one-month duration of dual antiplatelet therapy (DAPT) for high bleeding risk patients.

In June 2024, Boston Scientific Corporation, a medical technology company based in the US, acquired Silk Road Medical, Inc. for $1.18 billion. The acquisition aims to enhance Boston Scientific's product offerings and competitive position in the vascular market by leveraging innovative technologies to improve patient outcomes and expand into new markets. Silk Road Medical, Inc. is a medical device firm that focuses on developing innovative solutions for carotid artery procedures.

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

North America was the largest region in the bifurcation lesions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bifurcation lesions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the bifurcation lesions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The bifurcation lesions market includes revenues earned by proximal main branch (MB), distal MB and side branch (SB). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bifurcation Lesions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bifurcation lesions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bifurcation lesions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bifurcation lesions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types: One-Stent; Two-Stent
• 2) By Application: Coronary Vascular; Peripheral Vascular
• Subsegments:
• 1) By One-Stent: Single-Stent Deployment; Balloon-Expandable Stents; Self-Expanding Stents
• 2) By Two-Stent: Crush Technique; T- or Y-Configuration Stenting; Side Branch Stenting Techniques
• Companies Mentioned: Boston Scientific Corporation; Terumo Medical Corporation; Spectranetics Corporation; Medtronic plc; Cardinal Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bifurcation Lesions Market Characteristics

3. Bifurcation Lesions Market Trends And Strategies

4. Bifurcation Lesions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bifurcation Lesions Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bifurcation Lesions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bifurcation Lesions Market Growth Rate Analysis
• 5.4. Global Bifurcation Lesions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bifurcation Lesions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bifurcation Lesions Total Addressable Market (TAM)

6. Bifurcation Lesions Market Segmentation

• 6.1. Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• One-Stent
• Two-Stent
• 6.2. Global Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coronary Vascular
• Peripheral Vascular
• 6.3. Global Bifurcation Lesions Market, Sub-Segmentation Of One-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Stent Deployment
• Balloon-Expandable Stents
• Self-Expanding Stents
• 6.4. Global Bifurcation Lesions Market, Sub-Segmentation Of Two-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Crush Technique
• T- or Y-Configuration Stenting
• Side Branch Stenting Techniques

7. Bifurcation Lesions Market Regional And Country Analysis

• 7.1. Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bifurcation Lesions Market

• 8.1. Asia-Pacific Bifurcation Lesions Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bifurcation Lesions Market

• 9.1. China Bifurcation Lesions Market Overview
• 9.2. China Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bifurcation Lesions Market

• 10.1. India Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bifurcation Lesions Market

• 11.1. Japan Bifurcation Lesions Market Overview
• 11.2. Japan Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bifurcation Lesions Market

• 12.1. Australia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bifurcation Lesions Market

• 13.1. Indonesia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bifurcation Lesions Market

• 14.1. South Korea Bifurcation Lesions Market Overview
• 14.2. South Korea Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bifurcation Lesions Market

• 15.1. Western Europe Bifurcation Lesions Market Overview
• 15.2. Western Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bifurcation Lesions Market

• 16.1. UK Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bifurcation Lesions Market

• 17.1. Germany Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bifurcation Lesions Market

• 18.1. France Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bifurcation Lesions Market

• 19.1. Italy Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bifurcation Lesions Market

• 20.1. Spain Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bifurcation Lesions Market

• 21.1. Eastern Europe Bifurcation Lesions Market Overview
• 21.2. Eastern Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bifurcation Lesions Market

• 22.1. Russia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bifurcation Lesions Market

• 23.1. North America Bifurcation Lesions Market Overview
• 23.2. North America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bifurcation Lesions Market

• 24.1. USA Bifurcation Lesions Market Overview
• 24.2. USA Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bifurcation Lesions Market

• 25.1. Canada Bifurcation Lesions Market Overview
• 25.2. Canada Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bifurcation Lesions Market

• 26.1. South America Bifurcation Lesions Market Overview
• 26.2. South America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bifurcation Lesions Market

• 27.1. Brazil Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bifurcation Lesions Market

• 28.1. Middle East Bifurcation Lesions Market Overview
• 28.2. Middle East Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bifurcation Lesions Market

• 29.1. Africa Bifurcation Lesions Market Overview
• 29.2. Africa Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bifurcation Lesions Market Competitive Landscape And Company Profiles

• 30.1. Bifurcation Lesions Market Competitive Landscape
• 30.2. Bifurcation Lesions Market Company Profiles
  • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Terumo Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Spectranetics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bifurcation Lesions Market Other Major And Innovative Companies

• 31.1. Cardinal Health Company
• 31.2. Abbott Laboratories
• 31.3. Biosensors International Group Ltd.
• 31.4. B. Braun Melsungen AG
• 31.5. Cook Medical LLC
• 31.6. Cordis Corporation
• 31.7. Endologix Inc.
• 31.8. W. L. Gore & Associates Inc.
• 31.9. InspireMD Inc.
• 31.10. MicroPort Scientific Corporation
• 31.11. OrbusNeich Medical Company Limited
• 31.12. Biotronik SE & Co. KG
• 31.13. Cardionovum GmbH
• 31.14. Elixir Medical Corporation
• 31.15. Medinol Ltd.

32. Global Bifurcation Lesions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bifurcation Lesions Market

34. Recent Developments In The Bifurcation Lesions Market

35. Bifurcation Lesions Market High Potential Countries, Segments and Strategies

• 35.1 Bifurcation Lesions Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bifurcation Lesions Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bifurcation Lesions Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer